Literature DB >> 23123266

Croton lechleri sap and isolated alkaloid taspine exhibit inhibition against human melanoma SK23 and colon cancer HT29 cell lines.

Monica Montopoli1, Riccardo Bertin, Zheng Chen, Jenny Bolcato, Laura Caparrotta, Guglielmina Froldi.   

Abstract

ETHNOPHARMACOLOGICAL RELEVANCE: Croton lechleri Mull. Arg. (Euphorbiaceae) is a traditional medicinal plant which produces a red sap, traditionally known as "Sangre de Drago"; it is used in folk medicine externally for wounds, fractures, and haemorrhoids, internally for intestinal and stomach ulcers and also for the empirical cure of cancers.
MATERIALS AND METHODS: We investigated the effects of Croton lechleri sap and taspine in comparison with taxol and vinblastine on the growth of human cancer cell lines of SK23 (melanoma), LoVo and HT29 (colorectal cancer) using MTT and Trypan blue assays. Further, we studied cell cycle by flow cytometry and detected acetylated-α-tubulin by confocal microscope.
RESULTS: Croton lechleri inhibited cell proliferation starting from 1 μg/mL in SK23 cells, whereas 10 times higher concentrations were required for growth inhibition of HT-29 and LoVo cell lines. Also taspine (0.1 μg/mL) inhibited the SK23 and HT29 cell proliferation. Further, assay was assessed on SK23 and HT29 cell lines with 24-48 h treatment with sap and taspine. Both sap and taspine inhibited cancer cell proliferation; taspine showed higher activity on SK23 cells, which was significantly increased after 48 h of SK23 treatment. Using confocal microscopy we observed that Croton lechleri (1 μg/mL) caused a loss of microtubule structure, whereas taspine (0.5 μg/mL) caused an increase in acetylated α-tubulin and a modification of cellular morphology, mainly in SK23 cells. Croton lechleri sap 10 and 50 μg/mL influence cell cycle; 50 μg/mL sap caused a dramatic reduction of cells in G(1)/G(0) and S phases with a great increase of subG(0) cells.
CONCLUSIONS: The data showed that Croton lechleri and taspine could inhibit cell proliferation with higher potency against melanoma SK23 cells, supporting the empirical use of the sap as anticancer in ethnomedicine and taspine as a possible anticancer agent.
Copyright © 2012 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23123266     DOI: 10.1016/j.jep.2012.10.032

Source DB:  PubMed          Journal:  J Ethnopharmacol        ISSN: 0378-8741            Impact factor:   4.360


  5 in total

1.  Efficacy and Safety of Quxie Capsule () in Metastatic Colorectal Cancer: A Double-Blind Randomized Placebo Controlled Trial.

Authors:  Tong Zhang; Yu-Fei Yang; Bin He; Dan-Hui Yi; Jie Hao; Da Zhang
Journal:  Chin J Integr Med       Date:  2017-08-24       Impact factor: 1.978

2.  Preventive agents for neurodegenerative diseases from resin of Dracaena cochinchinensis attenuate LPS-induced microglia over-activation.

Authors:  Yingzhan Tang; Guangyue Su; Ning Li; Wenjie Li; Gang Chen; Ru Chen; Di Zhou; Yue Hou
Journal:  J Nat Med       Date:  2018-11-13       Impact factor: 2.343

Review 3.  How Should the Worldwide Knowledge of Traditional Cancer Healing Be Integrated with Herbs and Mushrooms into Modern Molecular Pharmacology?

Authors:  Yulia Kirdeeva; Olga Fedorova; Alexandra Daks; Nikolai Barlev; Oleg Shuvalov
Journal:  Pharmaceuticals (Basel)       Date:  2022-07-14

4.  Efficacy of Dragon's blood cream on wound healing: A randomized, double-blind, placebo-controlled clinical trial.

Authors:  Foroogh Namjoyan; Fatemeh Kiashi; Zahra Beigom Moosavi; Fatemeh Saffari; Behzad Sharif Makhmalzadeh
Journal:  J Tradit Complement Med       Date:  2015-01-22

5.  Novel findings to the biosynthetic pathway of magnoflorine and taspine through transcriptomic and metabolomic analysis of Croton draco (Euphorbiaceae).

Authors:  Anahí Canedo-Téxon; Feliza Ramón-Farias; Juan Luis Monribot-Villanueva; Emanuel Villafán; Alexandro Alonso-Sánchez; Claudia Anahí Pérez-Torres; Guillermo Ángeles; José Antonio Guerrero-Analco; Enrique Ibarra-Laclette
Journal:  BMC Plant Biol       Date:  2019-12-18       Impact factor: 4.215

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.